Why the study?
Are functional polymorphisms in UCP genes associated with a reduced prevalence of diabetes complications in patients with type 1 diabetes?
Are functional polymorphisms in UCP genes associated with a reduced prevalence of diabetes complications in patients with type 1 diabetes?
Polymorphisms in UCP2 and UCP3 genes are associated with a reduced risk of diabetic neuropathy in patients with type 1 diabetes, suggesting a protective role of higher uncoupling protein expression against mitochondria-mediated neuronal injury.
Answers are grounded in this paper and cite their sources.
Does not support practice change in type 1 diabetes; leaves open a protective role for UCP2/UCP3 variants against neuropathy.
OBJECTIVE: We studied the association between polymorphisms in the UCP genes and diabetes complications in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: We analyzed 227 patients with type 1 diabetes using PCR and subsequent cleavage by restriction endonucleases for the promoter variants A-3826G in the UCP1 gene, G-866A in the UCP2 gene, and C-55T in the UCP3 gene. RESULTS: No effect of the A-3826G polymorphism in the UCP1 gene on diabetes complications was found. Patients who were heterozygous or homozygous for the G-866A polymorphism in the UCP2 gene or the C-55T polymorphism in the UCP3 gene had a significantly reduced prevalence of diabetic neuropathy (UCP2: odds ratio 0.44 [95% CI 0.24-0.79], P = 0.007; UCP3: 0.48 [0.25-0.92], P = 0.031), whereas there was no association with other diabetes complications. This effect was stronger when G-866A and C-55T occurred in a cosegregatory manner (UCP2 and UCP3: 0.28 [0.12-0.65], P = 0.002). Furthermore, a multiple logistic regression model showed an age- and diabetes duration-independent effect of the cosegregated polymorphisms on the prevalence of diabetic neuropathy (P = 0.013). CONCLUSIONS: Our data indicate that both the G-866A polymorphism in the UCP2 gene and the C-55T polymorphism in the UCP3 gene are associated with a reduced risk of diabetic neuropathy in type 1 diabetes. Thus, the results presented here support the hypothesis that higher expression of uncoupling protein might prevent mitochondria-mediated neuronal injury and, ultimately, diabetic neuropathy.
No takes yet. Share an insight, caveat, or question.
Rudofsky et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: